{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Gastrointestinal epithelial barrier disorders",
      "relation": "indication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_mesalamine",
          "type": "Drug",
          "label": "Mesalamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_budesonide",
          "type": "Drug",
          "label": "Budesonide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tocilizumab",
          "type": "Drug",
          "label": "Tocilizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_loperamide",
          "type": "Drug",
          "label": "Loperamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_probiotics",
          "type": "Drug",
          "label": "Probiotics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_Gastrointestinal_epithelial_barrier_disorders",
          "type": "Disease",
          "label": "Gastrointestinal epithelial barrier disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "t_cytokine_receptor",
          "type": "Target",
          "label": "Cytokine Receptor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "t_inflammatory_marker",
          "type": "Target",
          "label": "Inflammatory Marker",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_inflammatory_response",
          "type": "Pathway",
          "label": "Inflammatory Response Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_barrier_function",
          "type": "Pathway",
          "label": "Epithelial Barrier Function Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_immune_modulation",
          "type": "Pathway",
          "label": "Immune Modulation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Mesalamine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Budesonide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Prednisone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Tocilizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Azathioprine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Loperamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Probiotics",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_mesalamine",
          "target": "t_inflammatory_marker",
          "relation": "modulates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "常用于减少肠道炎症"
        },
        {
          "source": "drug_infliximab",
          "target": "t_cytokine_receptor",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "对 TNF-α 抑制的有效性"
        },
        {
          "source": "drug_adalimumab",
          "target": "t_cytokine_receptor",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "作用机制与 infliximab 类似"
        },
        {
          "source": "drug_budesonide",
          "target": "p_inflammatory_response",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "类固醇减少免疫反应"
        },
        {
          "source": "drug_prednisone",
          "target": "p_inflammatory_response",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "可减少肠道炎症并降低组织损伤"
        },
        {
          "source": "drug_ustekinumab",
          "target": "t_cytokine_receptor",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "针对 IL-12/23 的新机制"
        },
        {
          "source": "drug_tocilizumab",
          "target": "t_cytokine_receptor",
          "relation": "inhibits",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "作用于 IL-6，调节免疫反应"
        },
        {
          "source": "drug_methotrexate",
          "target": "p_immune_modulation",
          "relation": "modulates",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "通过影响免疫应答来改善症状"
        },
        {
          "source": "drug_azathioprine",
          "target": "p_immune_modulation",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "免疫抑制药物，改善肠道健康"
        },
        {
          "source": "drug_cyclosporine",
          "target": "p_immune_modulation",
          "relation": "modulates",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "常作为免疫抑制治疗"
        },
        {
          "source": "drug_loperamide",
          "target": "p_barrier_function",
          "relation": "modulates",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "减轻腹泻，可改善屏障功能"
        },
        {
          "source": "drug_probiotics",
          "target": "p_barrier_function",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "通过调节肠道微生物促进肠道屏障"
        },
        {
          "source": "t_cytokine_receptor",
          "target": "p_inflammatory_response",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "细胞因子受体在炎症通路中起关键作用"
        },
        {
          "source": "t_inflammatory_marker",
          "target": "p_inflammatory_response",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "标记物与炎症活动相关"
        },
        {
          "source": "p_inflammatory_response",
          "target": "d_Gastrointestinal_epithelial_barrier_disorders",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "炎症过程直接影响肠道屏障功能"
        },
        {
          "source": "p_barrier_function",
          "target": "d_Gastrointestinal_epithelial_barrier_disorders",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "屏障功能损害导致临床表现"
        },
        {
          "source": "p_immune_modulation",
          "target": "d_Gastrointestinal_epithelial_barrier_disorders",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "免疫调节影响肠道健康"
        }
      ],
      "round_index": 1
    },
    "history": {
      "round": 1,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.73,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.7,
            "pk_pd_feasibility": 0.75,
            "indication_plausibility": 0.8,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.04
          },
          "graph_signals": {
            "support_weight": 2.55,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "通过调节炎症标记物，Mesalamine 直接改善肠道健康"
            ],
            "indication_plausibility": [
              "根据临床实践，Mesalamine 有效减少肠道炎症"
            ]
          },
          "confidence": "high"
        },
        {
          "hypothesis_id": "H2",
          "score": 0.82,
          "components": {
            "mechanism_fit": 0.9,
            "class_prior": 0.8,
            "pk_pd_feasibility": 0.75,
            "indication_plausibility": 0.85,
            "safety_risk": 0.05,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.03
          },
          "graph_signals": {
            "support_weight": 2.9,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Infliximab 有效抑制 TNF-α，显著改善炎症反应"
            ],
            "indication_plausibility": [
              "在临床研究中，Infliximab 显示出对肠道屏障的保护作用"
            ]
          },
          "confidence": "high"
        },
        {
          "hypothesis_id": "H3",
          "score": 0.8,
          "components": {
            "mechanism_fit": 0.9,
            "class_prior": 0.8,
            "pk_pd_feasibility": 0.75,
            "indication_plausibility": 0.85,
            "safety_risk": 0.05,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.04
          },
          "graph_signals": {
            "support_weight": 2.75,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Adalimumab 也能有效抑制 TNF-α，类似于 Infliximab 并能改善症状"
            ],
            "indication_plausibility": [
              "临床应用表明，Adalimumab 对于改善肠壁健康有效"
            ]
          },
          "confidence": "high"
        },
        {
          "hypothesis_id": "H4",
          "score": 0.76,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.7,
            "pk_pd_feasibility": 0.75,
            "indication_plausibility": 0.8,
            "safety_risk": 0.1,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.04
          },
          "graph_signals": {
            "support_weight": 2.3,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Budesonide 通过调节炎症通路改善肠道情况"
            ],
            "indication_plausibility": [
              "Budesonide 在临床中被用于治疗肠道炎症"
            ]
          },
          "confidence": "high"
        },
        {
          "hypothesis_id": "H5",
          "score": 0.72,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.75,
            "indication_plausibility": 0.75,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.07
          },
          "graph_signals": {
            "support_weight": 2.2,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Prednisone 能有效减轻炎症，但长期使用有副作用"
            ],
            "indication_plausibility": [
              "已用于改善肠道炎症，但需谨慎使用"
            ]
          },
          "confidence": "medium"
        },
        {
          "hypothesis_id": "H6",
          "score": 0.78,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.7,
            "pk_pd_feasibility": 0.75,
            "indication_plausibility": 0.8,
            "safety_risk": 0.1,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 2.6,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Ustekinumab 的新机制能够调节 IL-12/23，改善炎症反应"
            ],
            "indication_plausibility": [
              "研究表明 Ustekinumab 对消化系统有良好的效应"
            ]
          },
          "confidence": "medium"
        },
        {
          "hypothesis_id": "H7",
          "score": 0.65,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.7,
            "safety_risk": 0.1,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.08
          },
          "graph_signals": {
            "support_weight": 2.5,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Tocilizumab 通过调节 IL-6 对免疫反应有一定影响"
            ],
            "indication_plausibility": [
              "但证据不足以证明其对肠道屏障的直接作用"
            ]
          },
          "confidence": "medium"
        },
        {
          "hypothesis_id": "H8",
          "score": 0.6,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.65,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.08
          },
          "graph_signals": {
            "support_weight": 1.5,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Methotrexate 对免疫应答有一定影响，但不针对炎症过程"
            ],
            "indication_plausibility": [
              "不足以作为直接治疗肠道屏障的药物"
            ]
          },
          "confidence": "medium"
        },
        {
          "hypothesis_id": "H9",
          "score": 0.62,
          "components": {
            "mechanism_fit": 0.55,
            "class_prior": 0.55,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.65,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.09
          },
          "graph_signals": {
            "support_weight": 1.45,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Azathioprine 的免疫抑制特性，但对肠道薄弱的直接改善效果有限"
            ],
            "indication_plausibility": [
              "临床应用有限"
            ]
          },
          "confidence": "medium"
        },
        {
          "hypothesis_id": "H10",
          "score": 0.58,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.45,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.6,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 1.3,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Cyclosporine 的免疫调节作用不专门针对肠道屏障"
            ],
            "indication_plausibility": [
              "效果不明显，需结合其他药物治疗"
            ]
          },
          "confidence": "medium"
        },
        {
          "hypothesis_id": "H11",
          "score": 0.54,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.4,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.55,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.11
          },
          "graph_signals": {
            "support_weight": 1.2,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Loperamide 主要用于减轻腹泻，未直接改善肠道屏障"
            ],
            "indication_plausibility": [
              "适应症与研究领域不符"
            ]
          },
          "confidence": "medium"
        },
        {
          "hypothesis_id": "H12",
          "score": 0.68,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.75,
            "safety_risk": 0.1,
            "graph_bonus": 0.14,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 1.8,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Probiotics 通过调节肠道微生物群促进屏障功能"
            ],
            "indication_plausibility": [
              "有研究显示 Probiotics 对肠道健康的积极影响"
            ]
          },
          "confidence": "medium"
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_mesalamine",
            "via": [
              "t_inflammatory_marker"
            ],
            "to": "p_inflammatory_response",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          },
          {
            "type": "add_mechanism_link",
            "from": "drug_mesalamine",
            "via": [
              "t_inflammatory_marker"
            ],
            "to": "d_Gastrointestinal_epithelial_barrier_disorders",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "探讨 Mesalamine 对其它炎症标记物的调节作用",
          "界定 Mesalamine 的长期疗效与副作用"
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_infliximab",
            "via": [
              "t_cytokine_receptor"
            ],
            "to": "p_inflammatory_response",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          },
          {
            "type": "add_mechanism_link",
            "from": "drug_infliximab",
            "via": [
              "p_inflammatory_response"
            ],
            "to": "d_Gastrointestinal_epithelial_barrier_disorders",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "Infliximab 在炎症控制中的长效性与安全性",
          "Infliximab 对其它生物体的影响"
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_adalimumab",
            "via": [
              "t_cytokine_receptor"
            ],
            "to": "p_inflammatory_response",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          },
          {
            "type": "add_mechanism_link",
            "from": "drug_adalimumab",
            "via": [
              "p_inflammatory_response"
            ],
            "to": "d_Gastrointestinal_epithelial_barrier_disorders",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "Adalimumab 在临床中与 Infliximab 的比较",
          "探讨 Adalimumab 的长期效果与风险"
        ]
      }
    ],
    "pruned_hypotheses": [],
    "new_subhypotheses": [],
    "seed_request": {
      "should_regenerate": false,
      "reason": "路径独立性不足，需进一步补齐关键机制链接以提升图的连通性",
      "n": 4
    }
  }
}